SNCA and Parkinson disease: In the postmortem brain of PD patients, enrichment of H3K4me3 was observed in the regulatory region of SNCA and was positively correlated with α-synuclein level individuals, and the targeted attenuation reduced α-synuclein levels in the dopaminergic neurons [181].